Development of a Liposomal Dosage Form Based on Hydrophobic Derivative of Indolocarbazole-Reference-Cited by-同舟云学术

Development of a Liposomal Dosage Form Based on Hydrophobic Derivative of Indolocarbazole

Published:2020-08-29 Issue:3 Volume:9 Page:21-26
ISSN:2658-5049
Container-title:Drug development & registration
language:
Short-container-title:Razrabotka i registraciâ lekarstvennyh sredstv

Author:

Lugen B.¹^ORCID,Dmitrieva M. V.²^ORCID,Orlova O. L.²^ORCID,Krasnyuk I. I.¹^ORCID,Krasnyuk (jr.) I. I.¹^ORCID,Bokov D. O.¹^ORCID,Stepanova O. I.¹^ORCID,Belyackaya A. V.¹^ORCID

Affiliation:

1. I.M. Sechenov First MSMU of the Ministry of Health of the Russian Federation (Sechenov University)

2. Federal State Budgetary Institution «N.N. Blokhin National Medical Research Center of Oncology» оf the Ministry of Health of the Russian Federation (N. N. Blokhin NMRCO)

Publisher

Center of Pharmaceutical Analytics Ltd

Subject

Drug Discovery,Pharmaceutical Science

Reference16 articles.

1. Dezhenkova L. G., Tsvetkov V. B., Shtil A. A. Topoisomerase I and II inhibitors: chemical structure, mechanisms of action and role in tumor chemotherapy. Uspekhi Khimii. 2014;83(1):82-94. (In Russ.).

2. Wang W., Lv M., Zhao X., Zhang J. Developing a Novel Indolocarbazole as Histone Deacetylases Inhibitor against Leukemia Cell Lines. J Anal Methods Chem. 2015;675053:1-9. Doi: 10.1155/2015/675053.

3. Sanchez C., Zhu L., Brana A. F. et al. Combinatorial biosynthesis of antitumor indolocarbazole compounds. Proc Natl AcadSci USA. 2005;102(2):461-466. Doi: 10.1073/pnas.0407809102.

4. Melnik S. Ya., Vlasenkova N. K., Garayeva L. D. et al. Method for producing n-glycosides derived from indolo[2,3-a]pyrrolo[3,4-C]carbazole-5,7-diones with cytotoxic and antitumor activity. Patent Russia No. 2427585 dated 10.12.2009 (In Russ.).

5. Yavorskaya N. P., Golubeva I. S., Ektova L. V. et al. Antitumor activity of indolocarbazole LHS-1269. Rossijskij bioterapevticheskij zhurnal. 2016;15(1):125-126 (In Russ.).

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of the Composition and Technology for Production a Solid Dispersion System by Hot Melt Extrusion to Increase the Bioavailability of the Active Substance;Drug development & registration;2022-11-27

2. Quantitative determination of the N-glycoside derivative of substituted indolo[2,3a]carbazole in innovative dosage forms;Russian Journal of Biotherapy;2022-10-31

3. Relationship between genetic polymorphism of drug transporters and the efficacy of Rosuvastatin, atorvastatin and simvastatin in patients with hyperlipidemia;Lipids in Health and Disease;2021-11-08

4. ANTITUMOR DRUGS BASED ON INDOLOCARBAZOL DERIVATIVES;Pharmacy & Pharmacology;2021-09-08

5. SELECTION OF A CRYOPROTECTOR FOR PRODUCTION A LYOPHILIZED LIPOSOMAL DOSAGE FORM OF THE INDOLOCARBAZOLE DERIVATIVE LHS‑1269;Russian Journal of Biotherapy;2021-04-08